Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.

Walters E, Duvenhage J, Draper HR, Hesseling AC, Van Wyk SS, Cotton MF, Rabie H.

Arch Dis Child. 2014 Nov;99(11):998-1003. doi: 10.1136/archdischild-2013-305509. Epub 2014 Jun 17.

PMID:
24938535
2.

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 – CIPRA KH001) Study Team.

AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7.

PMID:
24096631
3.

The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.

Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5.

PMID:
19451858
4.

HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.

Martinson NA, Moultrie H, van Niekerk R, Barry G, Coovadia A, Cotton M, Violari A, Gray GE, Chaisson RE, McIntyre JA, Meyers T.

Int J Tuberc Lung Dis. 2009 Jul;13(7):862-7.

PMID:
19555536
5.

Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.

Mu W, Zhao Y, Sun X, Ma Y, Yu L, Liu X, Zhao D, Dou Z, Fang H, Zhang F.

AIDS Care. 2014;26(9):1127-35. doi: 10.1080/09540121.2014.882492. Epub 2014 Feb 10.

PMID:
24512621
6.

Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.

Wiseman CA, Schaaf HS, Cotton MF, Gie RP, Jennings T, Whitelaw A, Roux P, Hesseling AC.

Int J Tuberc Lung Dis. 2011 Jun;15(6):770-5. doi: 10.5588/ijtld.10.0501.

PMID:
21575297
7.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

8.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
9.

Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?

Anígilájé EA, Aderibigbe SA, Adeoti AO, Nweke NO.

PLoS One. 2016 May 27;11(5):e0156177. doi: 10.1371/journal.pone.0156177. eCollection 2016.

10.

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S.

Ann Intern Med. 2012 Sep 4;157(5):313-24. doi: 10.7326/0003-4819-157-5-201209040-00004.

11.

Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.

Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME.

PLoS One. 2011;6(7):e22706. doi: 10.1371/journal.pone.0022706. Epub 2011 Jul 29.

12.

Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy.

Bakeera-Kitaka S, Conesa-Botella A, Dhabangi A, Maganda A, Kekitiinwa A, Colebunders R, Boulware DR.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1082-6. doi: 10.5588/ijtld.10.0538.

13.

Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.

PLoS One. 2013;8(2):e55824. doi: 10.1371/journal.pone.0055824. Epub 2013 Feb 13.

14.

Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy.

Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ.

BMC Pediatr. 2008 Jan 11;8:1. doi: 10.1186/1471-2431-8-1.

15.

The impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010.

Lim MS, Dowdeswell RJ, Murray J, Field N, Glynn JR, Sonnenberg P.

PLoS One. 2012;7(6):e38598. doi: 10.1371/journal.pone.0038598. Epub 2012 Jun 22.

16.

Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.

Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ.

PLoS One. 2012;7(11):e40623. doi: 10.1371/journal.pone.0040623. Epub 2012 Nov 12.

17.

Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.

Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J.

Trans R Soc Trop Med Hyg. 2013 Apr;107(4):235-42. doi: 10.1093/trstmh/trt001. Epub 2013 Jan 16.

PMID:
23324313
19.

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation.

Agarwal U, Kumar A, Behera D, French MA, Price P.

AIDS Res Ther. 2012 May 23;9(1):17. doi: 10.1186/1742-6405-9-17.

20.

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team.

BMC Med. 2016 Mar 23;14:50. doi: 10.1186/s12916-016-0593-7.

Supplemental Content

Support Center